Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

04.11 2019
Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors
04.08 2019
Translate Bio Presents Preclinical Data Supporting MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
04.08 2019
Translate Bio Appoints Richard Wooster as Chief Scientific Officer
04.01 2019
Translate Bio Appoints Pasquale (Pat) Sacco as Senior Vice President of Technical Operations

View All

@TranslateBio